Aurora A Antibody

Skip to product information
1 of 2

Selleck Chemicals

SKU:F1175-20UL

Regular price €169,00 EUR
Regular price Sale price €169,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
Quantity
View full details

About the Target

AIK is a target of interest in many antibody-based workflows. Aurora kinases are a group of serine/threonine kinases that play a crucial role in the mitotic processes of all eukaryotic cells. Among them, Aurora-A is responsible for centrosome maturation and activation of the PLK1 kinase, which leads to the transition from the G2 phase to mitosis. Depending on the literature source, AIK may also be discussed as Aurora A and Aurora A/AIK.

Reported cellular context includes cytoplasm, cytoskeleton, microtubule, and centrosome, which can matter when signal is compared across treatments or changing cell states. Following AIK across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

AIK is commonly interpreted in the context of cancer, cell cycle, and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm, cytoskeleton, and microtubule, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

  • apparent redistribution between cytoplasm, cytoskeleton, and microtubule across matched conditions
  • changes associated with proliferative state, oncogenic signaling, or treatment response
  • cell-cycle linked differences in abundance, timing, or compartmental enrichment
  • signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for AIK. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in AIK reflect biology rather than handling. When interpreting AIK, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep AIK trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.

Targets:
AIK
Research Area:
Cancer • Cell Cycle • Cell Signaling
Application:
FCM • IF • WB
Reactivity:
Human • Mouse
Specificity:
Aurora A Antibody [P16M17] recognizes endogenous levels of total Aurora A protein.
Host:
Mouse
Clonality:
Monoclonal
Clone:
P16M17
UniProt:
O14965
Storage Buffer:
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.